Abstract
The moving epidemic method (MEM) and the WHO method are widely used to determine intensity levels for seasonal influenza. The two approaches are conceptually similar, but differ in two aspects. Firstly, the MEM involves a log transformation of incidence data, while the WHO method operates on the original scale. Secondly, the MEM uses more than one observation from each past season to compute intensity thresholds, fixing the total number to include. The WHO method uses only the highest value from each season. To assess the impact of these choices on thresholds we perform simulation studies which are based on re-sampling of ILI data from France, Spain, Switzerland and the US. When no transformation is applied, a rather large proportion of season peaks are classified as high or very high intensity. This can be mitigated by a logarithmic transformation. When fixing the total number of included past observations, thresholds increase the more seasons are available. When only few are available, there is a high chance of classifying new season peaks as high or very high intensity. We therefore suggest using one observation per season and a log transformation, i.e. a hybrid of the default settings of the MEM and WHO methods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Johannes Bracher was supported by the Helmholtz Foundation via the SIMCARD Information and Data Science Pilot Project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study uses exclusively publicly available epidemiological data at the national level. No ethics approval was necessary.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Materials to reproduce the presented results are available at https://github.com/jbracher/mem.
